by The Lead Podcast presented by Heart Rhythm Society
The Lead – a bi-weekly journal review podcast that is designed to keep you up to date and informed on the latest publications and hottest topics in electrophysiology. Key takeaways, in-depth interpretations, and informative interviews are all fitted into 15 minute time slots, so that they fit easily into your busy schedule. Click the link below to learn more!
Language
🇺🇲
Publishing Since
7/10/2023
Email Addresses
1 available
Phone Numbers
0 available
April 17, 2025
<p>Join host Michael S. Lloyd, MD,FHRS and episode participants Karim Benali, MD, PhD and Reinoud Knops, MD, PhD as they discuss this recent article that focuses on unique aspects of implantable defibrillators as experienced by young patients. The team gathered in person for this lively discussion at EHRA 2025 in Vienna. Bonus video footage of the episode is available on heartrhythm365.org.</p> <p>https://www.hrsonline.org/education/TheLead<br /> https://www.ahajournals.org/doi/10.1161/CIRCEP.124.013365</p> <p><br /> Host Disclosure(s):<br /> M. Lloyd:<br /> Honoraria/Speaking/Consulting: Medtronic, Arga Medtech, Circa Scientific<br /> Membership on Advisory Committees: Boston Scientific</p> <p> </p> <p>Contributor Disclosure(s):<br /> K. Benali:<br /> Nothing to disclose.</p> <p><br /> R. Knops:<br /> Honoraria/Speaking/Consulting: Boston Scientific, Metronic, Inc., Cairdac, Abbott<br /> Membership on Advisory Committees: Kestra, Inc.</p>
April 10, 2025
<p>Join host and Digital Education Chair Prashanthan Sanders, MBBS, PhD, FHRS, as he discusses this article from Nature with guests Anand N Ganesan, MBBS, PhD, and Tina Baykaner, MD, MPH. This trial was also presented as a late-breaking clinical trial at Heart Rhythm 2024.</p> <p> </p> <p>https://www.hrsonline.org/education/TheLead<br /> https://www.nature.com/articles/s41591-025-03517-w</p> <p> </p> <p>Host Disclosure(s):</p> <p>P. Sanders:<br /> Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical<br /> Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx,<br /> Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, Inc., Hello Alfred, Abbott Medical; Membership on Advisory Committees: Pacemate, Medtronic PLC, Boston Scientific, CathRx, Abbott Medical</p> <p>Contributor Disclosure(s):<br /> A. Ganesan: Honoraria/Speaking/Consulting: Biosense Webster, Inc.<br /> T. Baykaner: Honoraria/Speaking/Consulting: Medtronic, Pacemate, Volta Medical, iRhythm Technologies; Research: NIH</p> <p> </p> <p>This episode is worth 0.25 ACE credits. If you want credit for listening to this episode, please visit the episode page on HRS365: https://www.heartrhythm365.org/URL/TheLeadEpisode99</p>
April 2, 2025
<p>Host Melissa E. Middeldorp, MPH, PhD, of the University Medical Centre Groningen & University of Adelaide, is joined by Andrea Robinson, MSN, ACNP, from Riverside Methodist Hospital, OhioHealth, and Jeroen ML Hendriks, PhD, RN, of Maastricht University Medical Centre, in this episode.</p> <p>The AF-EduCare trial investigated whether targeted patient education (delivered in-person or online) could reduce unplanned cardiovascular events in patients with atrial fibrillation (AF). The study found that while education improved patient knowledge, medication adherence, and risk factor awareness, it did not significantly reduce cardiovascular hospitalizations, emergency visits, or mortality compared to standard care. However, subgroup analyses suggested that younger patients, those without heart failure, and asymptomatic AF patients might benefit more from in-person education. The findings highlight that while education enhances patient engagement, comprehensive medical management and timely clinical interventions remain the key drivers of improved cardiovascular outcomes in AF care. </p> <p>Join us for this in-depth conversation about the trial.</p> <p> </p> <p>https://www.hrsonline.org/education/TheLead<br /> https://academic.oup.com/europace/article/27/1/euae211/7964628</p> <p><br /> Host Disclosure(s):<br /> M. Middeldorp: Nothing to disclose.</p> <p><br /> Contributor Disclosure(s):<br /> A. Robinson: Honoraria/Speaking/Consulting: Medtronic, Inc., AtriCure, Inc., Biosense Webster, Inc.<br /> J. Kendriks: Honoraria/Speaking/Consulting: Biotronik</p> <p> </p> <p>This episode has .25 ACE credits associated with it. If you want credit for listening to this episode, please visit the episode page on HRS365: https://www.heartrhythm365.org/URL/TheLeadEpisode98</p>
Medscape
American College of Cardiology
American College of Cardiology
CardioNerds
The Moth
This American Life
WNYC Studios and The New Yorker
WNYC Studios
NPR
NPR
BBC Radio 4
New York Times Opinion
The New York Times
JAMA Network
NEJM Group
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.